Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy

/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today...

Related Keywords

Netherlands ,Australia ,Amsterdam ,Noord Holland ,Chicago ,Illinois ,United States ,Rush University ,Rush University Medical Center ,Utah ,Brisbane ,Queensland ,Salt Lake City ,Biocartis Idylla ,Prnewswire Immunexpress ,Maddie Stabinski ,Scott Stachowiak ,Immunexpres Septicyte ,Biocarti Idylla ,Richard Brandon ,European Union ,Association For Molecular Pathology ,Pty Ltd ,Immunexpress Inc ,Linkedin ,Rush Medical College ,Twitter ,Molecular Pathology ,Determining Probability ,Immunocompromised Patients ,Immunosuppressant Therapy ,Retrospective Physician Diagnosis ,Molecular Medicine ,Medicine Rush University Medical Center ,Crush Medical ,Chief Scientific Officer ,Immunexpress ,Nc ,